Thursday, November 1, 2018

  • Please join Dean Bernard T. Ferrari and the Carey Business School Real Estate Advisory Board for a fireside conversation between Toby Bozzuto, President & Chief Executive Officer, The Bozzuto Group, and Jeffrey Olson (Carey '01), Chairman and CEO of Urban Edge.

    Toby Bozzuto provides strategic and day-to-day leadership for more than 2,500 employees in eleven metropolitan areas. By fostering a strong corporate culture, he guides future growth and encourages the company to create extraordinary experiences for residents, clients, partners and each other. Toby regularly lends his real estate expertise to leading publications such as The Wall Street Journal and The Harvard Business Review, as well as media outlets such as CNBC, Marketplace, Bloomberg Media, and Baltimore’s NPR Station WYPR.

    Reception to follow.

     

    Business Professional Attire Required.

  • The JHU International Studies Program and the International Studies Affinity (Alumni) Group invite you to the annual International Studies Alumni Happy Hour. Come to reconnect with fellow alums, recent IS grads, and network with others within the IS community!

    The IS Program, together with a group of passionate alumni, created the International Studies Affinity Group to foster a deeper sense of interconnectedness within the Hopkins international studies community and to help current students develop their international affairs careers. Recognizing that international studies intersects with a range of other fields -- economics, political science, development, business, and tech, among others -- all Hopkins alumni interested in international studies-related fields are welcome to attend, regardless of one's completed major.

    Join us for lite fare and your first drink on us -- we can't wait to reconnect!

  • Healthcare and Biotech Affinities: New York

    The Microbiome and Cancer

    In the early 20th century, research findings of the nature of microbes upended the traditional understanding of science and medicine. A similar microbe-driven revolution may be afoot in oncology, as researchers uncover and untangle the relationships between the microbiome and cancer.

    Join the Biotech and Healthcare Affinity groups in a conversation featuring Dr. Cindy Sears, whose lab studies how certain bacteria can cause inflammation in the colon and subsequently influence the development of colitis or colon cancer. In addition, we’ll have speakers discussing the impact of these discoveries on clinical practitioners and research & development in Biotechnology, as well as a review of the currently accepted guidelines for Colorectal Screening.

    More on the Research

    Cindy Sears

    Dr. Sears and her team are working to understand how the microbiome may contribute to the genesis of an individual’s cancer development. This idea, which has been proposed in a variety of cancers, including those caused by the human papillomavirus (HPV), goes back 40 years. Thanks to new genomic testing tools and enhanced sophistication of a variety of scientific methods, scientists are finally able to address the concept in more detail.

    Cynthia L. Sears, M.D. is Professor of Medicine, Oncology and Molecular Microbiology and Immunology at the Johns Hopkins University School of Medicine and the Bloomberg School of Public Health. She is the Microbiome Program Leader of the Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins and is Director of the Johns Hopkins Germfree Murine Facility.  She is an infectious diseases expert who has focused on enteric infections for her career. In particular, she has studied the pathogenesis of enterotoxigenic Bacteroides fragilis (ETBF), both in the laboratory and in clinical settings, over the past 25 years. The current focus of the Sears laboratory is to determine how the microbiota and specific bacteria contribute to colon carcinogenesis. The Sears laboratory integrates studies in humans and mouse models, employing microbiology, bioinformatics and immunologic methods. Dr. Sears served as Associate Editor of Clinical Infectious Diseases from 2000 to 2016. She has been an active member of the Infectious Diseases Society of America (IDSA) for more than 20 years, serving the Society in numerous capacities. She is currently President-Elect of IDSA and assumes the presidency in October, 2018.